Qynapse

Qynapse, through QyScore, brings groundbreaking peace of mind to the global fight against CNS disease. Qyscore is a medical device software FDA-cleared – class II and CE-marked – class IIa (CE BSI). Qyscore is a medical device software FDA-cleared – class II and CE-marked – class IIa (CE BSI). QyScore is an advanced processing and visualization software for automatic labeling and volumetric quantification of segmented central nervous system structures for patients older than 18 years of age. The software is intended to be used by medical personnel or neuroimaging trained personnel to support diagnosis of central nervous system diseases. QyScore has demonstrated superior performance compared to certain other automated state-of-the-art methods and has been validated against gold-standard manual segmentation. FDA-Cleared and CE-Marked, QyScore® will be expanding soon into new global markets.